Literature DB >> 3022903

Chronic viral diseases.

B Berris.   

Abstract

Until 20 years ago the only chronic viral diseases known were those considered to be confined to the nervous system. As a result of recent advances in epidemiology, molecular biology and immunology, new viral diseases have been recognized and their clinical features and pathogenesis elucidated. Chronic disease may result from infection with the hepatitis B and D viruses and whatever agent or agents cause hepatitis non-A, non-B, the herpesviruses, Epstein-Barr virus, cytomegalovirus and human T-lymphotropic virus type III. These diseases have common features, including long-term or even lifetime asymptomatic carriage, viremia, with virus free in the plasma or attached to circulating mononuclear cells, presence of virus in body secretions, irreversible tissue injury in target organs and oncogenic potential. New information on these diseases is reviewed. Other chronic diseases for which the cause is currently unknown may eventually prove to be due to viral infection. In addition, vaccines may be developed for prophylaxis of some chronic viral diseases and associated malignant diseases.

Entities:  

Mesh:

Year:  1986        PMID: 3022903      PMCID: PMC1491381     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  66 in total

1.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

2.  Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma.

Authors:  G Giraldo; E Beth; E S Huang
Journal:  Int J Cancer       Date:  1980-07-15       Impact factor: 7.396

3.  Removal of hepatitis B surface antigen from a contaminated applanation tonometer.

Authors:  E Moniz; F Feldman; M Newkirk; S V Feinman; B Berris
Journal:  Am J Ophthalmol       Date:  1981-04       Impact factor: 5.258

4.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

5.  Isolation of human cytomegalovirus from peripheral blood T cells of renal transplant patients.

Authors:  H M Garnett
Journal:  J Lab Clin Med       Date:  1982-01

6.  Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.

Authors:  R D Schrier; J A Nelson; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

7.  The chronic sequelae of non-A, non-B hepatitis.

Authors:  M Berman; H J Alter; K G Ishak; R H Purcell; E A Jones
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

8.  Failure to detect hepatitis B surface antigen (HBsAg) in feces of HBsAg-positive persons.

Authors:  S V Feinman; B Berris; A Rebane; J C Sinclair; S Wilson; D Wrobel
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

9.  Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.

Authors:  H C Kim; P Saidi; A M Ackley; K A Bringelsen; D J Gocke
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

10.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

View more
  3 in total

1.  Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees.

Authors:  R Q Warren; H Wolf; K R Shuler; J W Eichberg; R A Zajac; R N Boswell; P Kanda; R C Kennedy
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

2.  Seroconversion to HBV associated with seroconversion to HIV in a cohort of intravenous drug misusers in Turin, Italy.

Authors:  A Sinicco; R Fora; M Sciandra; R Raiteri
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

3.  Development of a Bead-Based Multiplex Assay for the Analysis of the Serological Response against the Six Pathogens HAV, HBV, HCV, CMV, T. gondii, and H. pylori.

Authors:  Angela Filomena; Frank Pessler; Manas K Akmatov; Gérard Krause; Darragh Duffy; Barbara Gärtner; Markus Gerhard; Matthew L Albert; Thomas O Joos; Nicole Schneiderhan-Marra
Journal:  High Throughput       Date:  2017-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.